Our mission is to improve health, and one day save lives, with every flush

A letter from our co-founder

I was studying astrophysics and computer science at Harvard when I dropped out my sophomore year to start WHOOP. I spent the next decade there as co-founder and CTO. When we started, “wearable” wasn’t a word yet. Fitbit had just come out with something you put in your pocket.

What I learned building WHOOP was the power of collecting data on the human body day after day, outside the laboratory. That kind of data lets you build great products, and it moves forward what we know about health. We are still only scratching the surface.

Along the way, I was diagnosed with ulcerative colitis, a form of inflammatory bowel disease. When I was first diagnosed, I was hospitalized for 28 days straight and lost 60 pounds. The first three years were touch and go. Today I’m in remission.

My diagnosis threw me into the world of gut health, and I was amazed by how little we know about it: the gut-brain connection, the microbiome, diseases like mine. I wanted data to answer my own questions. WHOOP gave people data on their sleep and recovery. Selfishly, I wanted the same thing for my gut.

So I went looking for a smart toilet company to invest in. I didn’t find one I liked until I met Scott, whose opening line was “WHOOP for your poop.” I invested early, stayed close, and joined full time in March 2025.

I also serve on the board of trustees of the Crohn’s & Colitis Foundation. One of the most satisfying parts of this work has been the scientists who advise us. Many of them have only dreamed of having this kind of data.

Read John’s full story

John Capodilupo, Throne co-founder

John CapodilupoCo-founder and Chief Product Officer · Previously co-founder and CTO of WHOOP

See how Throne works

How Throne started

Both of my parents are doctors. My dad is also a medical device inventor, and my mom is a geriatrician, a doctor for adults 65 and up. When I asked her whether there was any medical value in what people leave in the toilet, it turned into a 45-minute phone call: my first masterclass on gut health.

She told me that probably a third of her patient visits were related to constipation. She had even stopped giving patients her phone number, because they sent her so many pictures of their poop.

That call sent me digging, and I was stunned by what I found. 60 to 70 million Americans are affected by digestive diseases, and millions more would simply feel better with a clearer picture of their gut health and hydration. We built Throne to give them that clarity.

It turned out to be personal, too. I later learned that both of my maternal grandparents had colon cancer, and that IBD runs on my dad’s side of the family. I had my first colonoscopy at 15. And testing early Throne prototypes taught me that stress is the number one driver of my own gut health.

Since starting Throne, the most rewarding part has been seeing how excited people are to finally have a health tracker for a part of their health that’s too often ignored.

Looking ahead, I’m deeply passionate about building a smoke detector for colon cancer. My vision is that someday, people will say “My toilet saved my life” or “Throne saved my mom’s life.” I can’t think of anything more motivating.

Scott Hickle, Throne co-founder

Scott HickleCo-founder and CEO

Watch Scott’s TEDxBoston talk

Scientific advisory board

Throne works with gastroenterologists and researchers from leading academic medical centers.

  • Dr. David Rubin

    Lead author, ulcerative colitis guidelines · UChicago Medicine

    Dr. David Rubin

    Lead author, ulcerative colitis guidelines · UChicago Medicine

    Dr. David Rubin helps set the standard for ulcerative colitis care. He is the lead author of the American College of Gastroenterology’s 2025 ulcerative colitis guidelines—the recommendations that guide doctors in treating adults with the disease.

    As Chief of Gastroenterology, Hepatology and Nutrition at UChicago Medicine, he combines patient care with research into Crohn’s disease and ulcerative colitis, bringing deep expertise in how digestive symptoms change over time.

  • Dr. Mark Pimentel

    Lead author, SIBO guideline · Cedars-Sinai

    Dr. Mark Pimentel

    Lead author, SIBO guideline · Cedars-Sinai

    Dr. Mark Pimentel is a pioneer in understanding the connection between gut bacteria and digestive symptoms. He is the lead author of the American College of Gastroenterology’s clinical guideline on small intestinal bacterial overgrowth (SIBO), helping define how doctors diagnose and treat the condition.

    He leads the MAST research program at Cedars-Sinai, where his team investigates the microbes behind bloating, altered bowel habits, and irritable bowel syndrome—and turns those discoveries into better tests and treatments.

  • Dr. Fola May

    Colorectal cancer prevention and health equity · UCLA

    Dr. Fola May

    Colorectal cancer prevention and health equity · UCLA

    Dr. Fola May is working to make lifesaving colorectal cancer screening reach more people. At UCLA, she leads research on improving access to high-quality digestive care and closing gaps in cancer prevention.

    She directs UCLA’s gastroenterology quality-improvement program and the May Health Services Research Laboratory, and serves as Associate Director of the UCLA Kaiser Permanente Center for Health Equity. Her work brings clinical medicine, public health, and patient advocacy together.

  • Dr. Aasma Shaukat

    Lead author, colorectal cancer screening guidelines · NYU Langone

    Dr. Aasma Shaukat

    Lead author, colorectal cancer screening guidelines · NYU Langone

    Dr. Aasma Shaukat helps shape how colorectal cancer is found early and prevented. She is the lead author of the American College of Gastroenterology’s 2021 colorectal cancer screening guidelines, which guide decisions about when and how people should be screened.

    As Director of Outcomes Research in gastroenterology at NYU Langone, she studies how to make screening more effective, improve colonoscopy quality, and turn research into better care for patients.

  • Dr. Satish Rao

    Pioneer in constipation treatment · Augusta University

    Dr. Satish Rao

    Pioneer in constipation treatment · Augusta University

    Dr. Satish Rao pioneered biofeedback therapy for a common cause of chronic constipation—helping patients retrain the muscles needed for a bowel movement. His work has advanced how doctors understand and treat problems with the way the gut moves.

    He holds the Harrison Distinguished Chair in Gastroenterology at Augusta University and co-authored the American College of Gastroenterology’s SIBO guideline. His expertise connects everyday bowel symptoms with the science of gut function.

  • Dr. Vipul Jairath

    IBD clinical-trial leader · Western University

    Dr. Vipul Jairath

    IBD clinical-trial leader · Western University

    Dr. Vipul Jairath helps determine whether new treatments for Crohn’s disease and ulcerative colitis truly work. His research shapes how clinical trials are designed and how they measure meaningful improvements in patients’ lives.

    A Professor of Medicine and holder of the McDonald Endowed Chair in IBD Clinical Research at Western University, he trained in gastroenterology in London and Oxford. Western credits his work with directly influencing clinical-trial design, regulatory science, and patient care.

What members say

“I’ve surprised myself — my gut health is better than I thought. So that’s reassuring.”

Amanda G.

“The hydration was a big key. I had no way of knowing if I was hydrated. And I use it all the time.”

Ray S.

“It works for the data nerds like me, but it also works for the totally normal humans like my wife.”

Dave J.

Backed by

Throne installed on a toilet in a sunlit spa bathroom

Listen to your gut

Track your gut health and hydration automatically, from your own bathroom.

Start tracking today
  • HSA/FSA eligible

Your cart

0

Your cart is empty.

Explore Throne for hands-free gut health and hydration insights.

Shop Throne
0 items in your cart. Subtotal $0.00 USD.